BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 17617120)

  • 21. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
    Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M
    Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
    Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
    J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.
    Chen RX; Xia YH; Cui JF; Xue TC; Ye SL
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
    Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
    Tseng PL; Tai MH; Huang CC; Wang CC; Lin JW; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    J Surg Oncol; 2008 Oct; 98(5):349-57. PubMed ID: 18646041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer.
    Anttila MA; Kosma VM; Hongxiu J; Puolakka J; Juhola M; Saarikoski S; Syrjänen K
    Br J Cancer; 1999 Apr; 79(11-12):1870-8. PubMed ID: 10206307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas.
    Hui AM; Kanai Y; Sakamoto M; Tsuda H; Hirohashi S
    Hepatology; 1997 Mar; 25(3):575-9. PubMed ID: 9049201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
    Osada S; Saji S; Kuno T
    J Surg Oncol; 2004 Jan; 85(1):48-54. PubMed ID: 14696087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
    Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM
    Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas.
    Shi YZ; Hui AM; Takayama T; Li X; Cui X; Makuuchi M
    Br J Cancer; 2000 Jul; 83(1):50-5. PubMed ID: 10883667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential].
    Saiki I; Une Y; Uchino J
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():103-9. PubMed ID: 7611770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
    Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
    J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
    Claudio PP; Russo G; Kumar CA; Minimo C; Farina A; Tutton S; Nuzzo G; Giuliante F; Angeloni G; Maria V; Vecchio FM; Campli CD; Giordano A
    Clin Cancer Res; 2004 May; 10(10):3509-17. PubMed ID: 15161709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary.
    Werness BA; Freedman AN; Piver MS; Romero-Gutierrez M; Petrow E
    Gynecol Oncol; 1999 Dec; 75(3):413-8. PubMed ID: 10600299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression and significance of cell cycle regulators in gastric carcinoma].
    Wu JF; Shao JC; Wang DB; Qin R; Zhang H
    Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p21(WAF1) expression and endocrine response in breast cancer.
    McClelland RA; Gee JM; O'Sullivan L; Barnes DM; Robertson JF; Ellis IO; Nicholson RI
    J Pathol; 1999 Jun; 188(2):126-32. PubMed ID: 10398154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
    Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
    Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
    Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.